We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+13.33%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$54.8B
AUM Growth
+$4.24B
(+8.4%)
Cap. Flow
-$502M
Cap. Flow
% of AUM
-0.92%
Top 10 Holdings %
Top 10 Hldgs %
29.94%
Holding
1,776
New
37
Increased
449
Reduced
1,142
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$158M |
| 2 |
Uber
UBER
|
+$110M |
| 3 |
Blackstone Secured Lending
BXSL
|
+$97.3M |
| 4 |
Amazon
AMZN
|
+$76.3M |
| 5 |
PayPal
PYPL
|
+$75.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$184M |
| 2 |
Crown Castle
CCI
|
+$173M |
| 3 |
CME Group
CME
|
+$125M |
| 4 |
Gilead Sciences
GILD
|
+$119M |
| 5 |
Amgen
AMGN
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.81% |
| 2 | Healthcare | 15.16% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHUY
1401
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $893K | ﹤0.01% |
26,488
-1,336
| -5% | -$45.6K |
|
1402
PagerDuty
PD
$795M
| $892K | ﹤0.01% |
39,326
-1,984
| -5% | -$47.1K |
|
|
HTO
1403
H2O America
HTO
$2.69B
| $889K | ﹤0.01% |
15,708
-792
| -5% | -$47K |
|
|
RWT
1404
Redwood Trust
RWT
$585M
| $888K | ﹤0.01% |
139,369
-7,031
| -5% | -$45.9K |
|
1405
Kennametal
KMT
$2.71B
| $884K | ﹤0.01% |
35,459
-1,789
| -5% | -$44K |
|
1406
Kulicke & Soffa
KLIC
$4.76B
| $881K | ﹤0.01% |
17,520
-884
| -5% | -$44.2K |
|
1407
Employers Holdings
EIG
$912M
| $880K | ﹤0.01% |
19,387
-978
| -5% | -$41.8K |
|
1408
Doximity
DOCS
$3.85B
| $876K | ﹤0.01% |
32,558
-1,642
| -5% | -$46.8K |
|
|
ALEX
1409
DELISTED
Alexander & Baldwin
ALEX
| $876K | ﹤0.01% |
53,180
-2,683
| -5% | -$46.1K |
|
1410
Concentrix
CNXC
$1.55B
| $873K | ﹤0.01% |
13,187
-665
| -5% | -$54K |
|
|
FL
1411
DELISTED
Foot Locker
FL
| $873K | ﹤0.01% |
30,616
-1,544
| -5% | -$44.4K |
|
1412
Unifirst Corp
UNF
$5.43B
| $868K | ﹤0.01% |
5,003
-252
| -5% | -$42.8K |
|
1413
Bank of Hawaii
BOH
$3.17B
| $867K | ﹤0.01% |
13,895
-701
| -5% | -$44.4K |
|
1414
Delek US
DK
$3.85B
| $865K | ﹤0.01% |
28,150
-1,420
| -5% | -$38.4K |
|
|
EQC
1415
DELISTED
Equity Commonwealth
EQC
| $864K | ﹤0.01% |
45,781
-2,309
| -5% | -$43.9K |
|
1416
Lakeland Financial Corp
LKFN
$1.58B
| $862K | ﹤0.01% |
12,994
-656
| -5% | -$42.4K |
|
1417
Gentherm
THRM
$1.29B
| $860K | ﹤0.01% |
14,929
-753
| -5% | -$39.2K |
|
1418
QuantumScape Corp
QS
$3.18B
| $854K | ﹤0.01% |
135,748
+348
| +0.3% | +$2.34K |
|
|
PRO
1419
DELISTED
PROS Holdings
PRO
| $853K | ﹤0.01% |
23,485
-1,185
| -5% | -$41.9K |
|
1420
Collegium Pharmaceutical
COLL
$1.16B
| $852K | ﹤0.01% |
21,943
-1,107
| -5% | -$38.7K |
|
1421
Supernus Pharmaceuticals
SUPN
$2.77B
| $849K | ﹤0.01% |
24,890
-1,256
| -5% | -$37.4K |
|
|
DNB
1422
DELISTED
Dun & Bradstreet
DNB
| $849K | ﹤0.01% |
84,545
-4,265
| -5% | -$46.6K |
|
1423
Hope Bancorp
HOPE
$1.8B
| $848K | ﹤0.01% |
73,643
-3,715
| -5% | -$41.7K |
|
1424
Trinity Industries
TRN
$3.03B
| $847K | ﹤0.01% |
30,416
-1,534
| -5% | -$39.5K |
|
1425
WaFd
WAFD
$2.71B
| $845K | ﹤0.01% |
29,120
-1,469
| -5% | -$42.3K |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Ensign Peak Advisors held 1,776 positions worth $54.8B, up 8.4% from $50.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 5%. Ensign Peak Advisors opened 37 new positions and exited 51, leaving the 1,776-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q1 2024 buy was Blackstone Secured Lending: 3,319,725 shares worth $103M.
- Ensign Peak Advisors added most to Eli Lilly in Q1 2024, an estimated $158M increase.
- Ensign Peak Advisors's biggest Q1 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $184M.
- Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $66.5M.
- Ensign Peak Advisors's ten largest holdings make up 30% of its $54.8B portfolio in Q1 2024.
- Ensign Peak Advisors opened 37 new positions and closed 51 in Q1 2024.
- Ensign Peak Advisors's portfolio value rose 8.4% quarter-over-quarter to $54.8B.
Based on Ensign Peak Advisors's 13F filing for Q1 2024, filed 14 May 2024.